Glenmark Pharmaceuticals receives ANDA approval for Fluocinolone Acetonide Topical Oil

Deepthi | Myequity news | Date : 30-10-2018 09:20:00 IST


Glenmark Pharmaceuticals Inc., USA has been granted final approval by the United States Food & Drug Administration (U.S. FDA) for Fluocinolone Acetonide Topical Oil, 0.01% (Scalp Oil), a generic version of Derma-Smoothe/FS®1 Topical Oil, 0.01% (Scalp Oil), of Hill Dermaceuticals, Inc.

According to IQVIATM sales data for the 12 month period ending September 2018, the Derma- Smoothe/FS® Topical Oil, 0.01% (Scalp Oil) market2 achieved annual sales of approximately $14.0 million*.

About Glenmark Pharmaceuticals

Glenmark Pharmaceuticals Ltd. (GPL) is a research-driven, global, integrated pharmaceutical organization. Glenmark is a leading player in the discovery of new molecules both NCEs (new chemical entity) and NBEs (new biological entity). Glenmark has several molecules in various stages of clinical development and is focused in the areas of oncology, dermatology and respiratory.

 


More from Myequity